VLADIVOSTOK, April 11 (Xinhua) The Russian government will allocate 387 million rubles (about 4.8 million U.S. dollars) to produce Mir-19, a new anti-coronav
Russia s Federal Medical, Biological Agency permitted to conduct clinical trials of coronavirus medication
MOSCOW. Dec 30 (Interfax) - Russia s Federal Medical and Biological Agency (FMBA) will begin clinical trials of a coronavirus medication that has shown 99% efficacy during preclinical trials, the agency s press service said. FMBA was permitted by the Russian Health Ministry to conduct a clinical trial of a medication for the treatment of Covid-19, the FMBA press service said in a statement released on Wednesday.
As part of the first phase of trials, it is planned to explore the safety and tolerability of the medication on healthy volunteers. The research will be carried out at the Institute of Immunology of the Federal Medical and Biological Agency. Now, the testing center is preparing for clinical trials, and volunteers are being recruited.